86 related articles for article (PubMed ID: 16465854)
1. [Unnecessary to scare the patients].
Hansen B; Book C
Lakartidningen; 2006 Jan 11-17; 103(1-2):63. PubMed ID: 16465854
[No Abstract] [Full Text] [Related]
2. [TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis. Six case reports].
Tengstrand B; Ernestam S; Engvall IL; Rydvald Y; Hafström I
Lakartidningen; 2005 Dec 5-11; 102(49):3788-90, 3793. PubMed ID: 16408702
[TBL] [Abstract][Full Text] [Related]
3. Psoriasiform and pustular eruption induced by etanercept and infliximab.
Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
[No Abstract] [Full Text] [Related]
4. Pulsating back pain associated with tumor necrosis factor-alpha blockade.
Rozin AP; Braun-Moscovici Y; Balbir-Gurman A
Ann Pharmacother; 2008 Dec; 42(12):1912-3. PubMed ID: 19033477
[No Abstract] [Full Text] [Related]
5. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
[TBL] [Abstract][Full Text] [Related]
6. [Serious lung disease in RA and TNF-blockade--is there a connection?].
Turesson C; Jacobsson L; Saxne T; Geborek P
Lakartidningen; 2006 Feb 1-7; 103(5):308; author reply 308-9. PubMed ID: 16512575
[No Abstract] [Full Text] [Related]
7. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
[No Abstract] [Full Text] [Related]
8. Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases.
Dereure O; Guillot B; Jorgensen C; Cohen JD; Combes B; Guilhou JJ
Br J Dermatol; 2004 Aug; 151(2):506-7. PubMed ID: 15327565
[No Abstract] [Full Text] [Related]
9. Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs.
Curtis JR; Martin C; Saag KG; Patkar NM; Kramer J; Shatin D; Allison J; Braun MM
Arthritis Rheum; 2007 Mar; 57(2):343-6. PubMed ID: 17330283
[No Abstract] [Full Text] [Related]
10. Adalimumab-associated pulmonary fibrosis reply.
Huggett MT; Armstrong R
Rheumatology (Oxford); 2007 Aug; 46(8):1379-80; author reply 1379. PubMed ID: 17553912
[No Abstract] [Full Text] [Related]
11. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis.
Giles JT; Bartlett SJ; Gelber AC; Nanda S; Fontaine K; Ruffing V; Bathon JM
Arthritis Rheum; 2006 Apr; 55(2):333-7. PubMed ID: 16583385
[No Abstract] [Full Text] [Related]
12. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.
Malesci D; La Montagna G
Rheumatology (Oxford); 2008 May; 47(5):734-5. PubMed ID: 18326535
[No Abstract] [Full Text] [Related]
13. Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis.
Ognenovski VM; Ojo TC; Fox DA
J Rheumatol; 2008 Nov; 35(11):2279-82. PubMed ID: 19004058
[No Abstract] [Full Text] [Related]
14. Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis.
Day R
Lancet; 2002 Feb; 359(9306):540-1. PubMed ID: 11867103
[No Abstract] [Full Text] [Related]
15. Tuberculosis and treatment with infliximab.
Myers A; Clark J; Foster H
N Engl J Med; 2002 Feb; 346(8):623-6. PubMed ID: 11859881
[No Abstract] [Full Text] [Related]
16. Pulmonary rheumatoid nodules in an etanercept-treated patient.
Hübscher O; Re R; Iotti R
Arthritis Rheum; 2003 Jul; 48(7):2077-8. PubMed ID: 12847707
[No Abstract] [Full Text] [Related]
17. Etanercept-induced dermatitis in a patient with rheumatoid arthritis.
Lai-Cheong J; Warren R; Bucknall R; Parslew R
J Eur Acad Dermatol Venereol; 2006 May; 20(5):614-5. PubMed ID: 16684300
[No Abstract] [Full Text] [Related]
18. Tuberculosis and anti-TNF-alpha treatment.
Ormerod LP
Thorax; 2004 Nov; 59(11):921. PubMed ID: 15516463
[No Abstract] [Full Text] [Related]
19. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
Watson P; Simler N; Screaton N; Lillicrap M
Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
[No Abstract] [Full Text] [Related]
20. Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?
Richette P; Viguier M; Bachelez H; Bardin T
J Rheumatol; 2007 Feb; 34(2):438-9. PubMed ID: 17304662
[No Abstract] [Full Text] [Related]
[Next] [New Search]